Nucleic Acid Testing Market, By Product Type (Instruments, Reagents and Consumables, and Software and Services), By Technology, By Application, By End-user, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4071
|
Published Date
June 2025
|
Pages
303
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Nucleic Acid Testing Market size was valued at US$ 3,290.32 Million in 2024, expanding at a CAGR of 5.50% from 2025 to 2032.
Nucleic Acid Testing (NAT) is a molecular diagnostic technique that detects specific nucleic acids—DNA or RNA—of pathogens, genetic disorders, or other biological targets. It is essential for identifying infectious diseases such as HIV, hepatitis, and COVID-19 by amplifying and detecting the genetic material of viruses or bacteria with high sensitivity and accuracy. Compared to traditional methods like culture or antibody testing, NAT provides faster results, enabling early diagnosis and improved patient management. This technology is widely utilized in blood screening, clinical diagnostics, forensic analysis, and research.
Advancements in amplification techniques such as Polymerase Chain Reaction (PCR) have established NAT as a gold standard in medical diagnostics. The growing prevalence of infectious diseases, increasing demand for rapid and precise testing, and expanding applications in personalized medicine and biotechnology are driving market growth. Additionally, continuous innovation and rising adoption in developing countries contribute to the market’s expansion. Overall, NAT plays a critical role in early disease detection, significantly enhancing healthcare outcomes worldwide.
Nucleic Acid Testing Market- Market Dynamics
Rising Demand for Rapid and Accurate Infectious Disease Detection Fuels Market Growth
The growing demand for rapid and accurate detection of infectious diseases is a key driver of the nucleic acid testing (NAT) market. Diseases such as COVID-19, HIV, hepatitis, and influenza require timely diagnosis to control their spread and ensure prompt treatment. Traditional diagnostic methods often have longer turnaround times and may lack the sensitivity necessary for early-stage detection. NAT overcomes these limitations by delivering fast, highly sensitive, and specific results, enabling healthcare providers to make quicker and more informed decisions. According to the World Health Organization (WHO), early detection and diagnosis can reduce mortality rates from infectious diseases by up to 30%, prompting over 80% of governments worldwide to invest in advanced diagnostic technologies such as NAT.
NAT’s ability to detect even low levels of viral or bacterial genetic material allows for identification of infections at early stages, which is critical for effective disease management and containment. The increasing frequency of infectious disease outbreaks and the need for large-scale testing during pandemics have further accelerated global adoption of NAT technologies. Moreover, governments and healthcare organizations worldwide are prioritizing early detection as a strategy to reduce disease burden and healthcare expenses. For instance, the Global Fund reported that countries utilizing NAT for HIV and tuberculosis diagnosis have seen a 25% improvement in treatment outcomes, underscoring government commitment to these technologies. This heightened focus on rapid diagnostics fuels ongoing innovation and expanded use of nucleic acid testing in hospitals, laboratories, and blood screening centers, driving substantial growth in the market.
Nucleic Acid Testing Market- Segmentation Analysis:
The Global Nucleic Acid Testing Market is segmented on the basis of Product Type, Technology, Application, End-user, and Region.
The nucleic acid testing market is segmented into three primary categories based on product type: Instruments, Reagents and Consumables, and Software and Services. Among these, Reagents and Consumables hold a dominant position due to their vital role in ensuring accurate and reliable nucleic acid testing. This category includes essential components such as enzymes, primers, probes, buffers, and other chemicals required for the amplification and detection of nucleic acids. Unlike instruments, reagents are consumable items that need to be regularly replenished, which drives consistent demand and generates a steady revenue stream for market participants. According to recent government data, reagent consumption in molecular diagnostics has grown by more than 20% annually over the past few years, underscoring the increasing reliance on nucleic acid testing within healthcare systems worldwide. The quality of these reagents directly impacts test sensitivity and specificity, making them crucial to maintaining the accuracy and reliability of molecular diagnostic procedures.
The nucleic acid testing market is also categorized by technology into five segments: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Isothermal Amplification, Microarray, and Others. Among these, PCR remains the leading technology due to its exceptional sensitivity, specificity, and rapid turnaround time. PCR enables the amplification of minute quantities of DNA or RNA, allowing for the detection of low levels of pathogens or genetic material. It is widely used in clinical diagnostics, infectious disease testing, and genetic research. Government health reports indicate that PCR testing accounted for nearly 70% of all nucleic acid-based diagnostic procedures conducted in public health laboratories last year, reflecting its broad adoption and critical role in molecular diagnostics. The technology’s versatility and well-established protocols have solidified PCR as the global gold standard for nucleic acid testing. Moreover, ongoing advancements such as real-time PCR continue to enhance its accuracy and efficiency, ensuring PCR maintains its dominant position in the market.
Nucleic Acid Testing Market- Geographical Insights
North America holds a strong position in the nucleic acid testing market due to advanced healthcare infrastructure and widespread adoption of cutting-edge diagnostic technologies.
The North American region benefits from significant investments in research and development, coupled with strong regulatory support for molecular diagnostics, which collectively drive robust growth in the nucleic acid testing market. High awareness about the importance of early disease detection, along with government initiatives aimed at improving healthcare outcomes, further fuel market expansion. The region also boasts the presence of major diagnostic laboratories and increasing integration of nucleic acid testing (NAT) in clinical settings, which reinforce North America’s leadership position in this field. According to recent government health reports, federal funding for molecular diagnostic research in North America has increased by over 15% annually, underscoring the region’s commitment to advancing this technology.
The United States plays a pivotal role in the nucleic acid testing market, supported by its advanced healthcare infrastructure and a strong biotechnology research ecosystem. Leading companies in the U.S. are at the forefront of innovation, particularly in Polymerase Chain Reaction (PCR) and next-generation sequencing (NGS) technologies. Federal funding programs and regulatory frameworks, including rigorous FDA oversight of molecular diagnostics, enhance market credibility and foster growth. Government data indicates that over 80% of public health laboratories in the U.S. utilize NAT for infectious disease detection, oncology, and genetic testing, reflecting widespread adoption. Additionally, an increasing emphasis on personalized medicine and chronic disease management is expected to drive further demand for nucleic acid testing solutions, solidifying the U.S.’s position as a global leader in the development and deployment of these advanced diagnostic tools.
Nucleic Acid Testing Market- Competitive Landscape:
The nucleic acid testing (NAT) market is highly competitive, with key players continuously innovating to enhance test accuracy, speed, and ease of use. Leading companies such as Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics, Danaher Corporation, and Qiagen dominate the market by offering a wide array of advanced molecular diagnostic solutions. These organizations invest heavily in research and development to improve technologies including real-time PCR, next-generation sequencing, and isothermal amplification. Strategic partnerships, mergers, and acquisitions are frequent as companies seek to broaden their product portfolios and expand their global footprint.
Additionally, firms like Cepheid, Bio-Rad Laboratories, Illumina, and Hologic focus on developing automated and high-throughput testing systems to meet the increasing clinical and research demands. Regulatory compliance and cost efficiency remain crucial factors driving competition within the industry. Smaller companies and startups also play a vital role by introducing specialized innovations and point-of-care testing solutions. This dynamic competitive landscape fosters rapid technological advancements and promotes the wider adoption of nucleic acid testing worldwide, contributing to continuous improvements in disease detection and personalized medicine.
Recent Developments:
- In December 2023, Thermo Fisher Scientific launched the Thermo Scientific™ KingFisher™ Apex™ Dx, an automated nucleic acid purification instrument, alongside the Applied Biosystems™ MagMAX™ Dx Viral/Pathogen NA Isolation Kit. These products are designed to streamline respiratory diagnostic testing by automating the extraction of viral and bacterial nucleic acids from respiratory specimens.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL NUCLEIC ACID TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific
- Abbott Laboratories
- Roche Diagnostics
- Danaher Corporation
- Qiagen
- Becton, Dickinson and Company (BD)
- Hologic, Inc.
- Cepheid (a Danaher company)
- Bio-Rad Laboratories
- Illumina, Inc.
- PerkinElmer, Inc.
- Agilent Technologies
- Luminex Corporation
- Sysmex Corporation
- BioMérieux
- F. Hoffmann-La Roche AG
GLOBAL NUCLEIC ACID TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Instruments
- Reagents and Consumables
- Software and Services
GLOBAL NUCLEIC ACID TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- Isothermal Amplification
- Microarray
- Others
GLOBAL NUCLEIC ACID TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Infectious Disease Testing
- Oncology Testing
- Genetic Testing
- Blood Screening
- Others
GLOBAL NUCLEIC ACID TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals and Clinics
- Diagnostic Laboratories
- Blood Banks
- Research Laboratories
- Others
GLOBAL NUCLEIC ACID TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Nucleic Acid Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Nucleic Acid Testing Market Snippet by Product Type
2.1.2. Nucleic Acid Testing Market Snippet by Technology
2.1.3. Nucleic Acid Testing Market Snippet by Application
2.1.4. Nucleic Acid Testing Market Snippet by End-user
2.1.5. Nucleic Acid Testing Market Snippet by Country
2.1.6. Nucleic Acid Testing Market Snippet by Region
2.2. Competitive Insights
3. Nucleic Acid Testing Key Market Trends
3.1. Nucleic Acid Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Nucleic Acid Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Nucleic Acid Testing Market Opportunities
3.4. Nucleic Acid Testing Market Future Trends
4. Nucleic Acid Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Nucleic Acid Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Nucleic Acid Testing Market Landscape
6.1. Nucleic Acid Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Nucleic Acid Testing Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Instruments
7.1.3. Reagents and Consumables
7.1.4. Software and Services
8. Nucleic Acid Testing Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. Polymerase Chain Reaction (PCR)
8.1.3. Next-Generation Sequencing (NGS)
8.1.4. Isothermal Amplification
8.1.5. Microarray
8.1.6. Others
9. Nucleic Acid Testing Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Infectious Disease Testing
9.1.3. Oncology Testing
9.1.4. Genetic Testing
9.1.5. Blood Screening
9.1.6. Others
10. Nucleic Acid Testing Market – By End-user
10.1. Overview
10.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
10.1.2. Hospitals and Clinics
10.1.3. Diagnostic Laboratories
10.1.4. Blood Banks
10.1.5. Research Laboratories
10.1.6. Others
11. Nucleic Acid Testing Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Nucleic Acid Testing Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.2.8. The U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Nucleic Acid Testing Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Nucleic Acid Testing Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Nucleic Acid Testing Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Nucleic Acid Testing Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Nucleic Acid Testing Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Thermo Fisher Scientific
12.2.2. Abbott Laboratories
12.2.3. Roche Diagnostics
12.2.4. Danaher Corporation
12.2.5. Qiagen
12.2.6. Becton, Dickinson and Company (BD)
12.2.7. Hologic, Inc.
12.2.8. Cepheid (a Danaher company)
12.2.9. Bio-Rad Laboratories
12.2.10. Illumina, Inc.
12.2.11. PerkinElmer, Inc.
12.2.12. Agilent Technologies
12.2.13. Luminex Corporation
12.2.14. Sysmex Corporation
12.2.15. BioMérieux
12.2.16. F. Hoffmann-La Roche AG
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
